CPEB1-AS1: A Potential Drug Target and Biomarker (G283692)

Target Name: CPEB1-AS1

NCBI ID: G283692

CPEB1-AS1

Other Name(s): CPEB1 antisense RNA 1

CPEB1-AS1: A Potential Drug Target and Biomarker

Introduction

CPeB1-AS1 (CPEB1 Antisense RNA 1) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. CPeB1-AS1 is a key regulator of the cell's transcriptional machinery, and its levels have been shown to be highly Correlated with various diseases, including cancer. The identification of CPeB1-AS1 as a potential drug target has significant implications for the development of new therapeutic strategies for these diseases.

CPEB1-AS1 Structure and Function

CPeB1-AS1 is a small non-coding RNA molecule that was identified using RNA-seq technology. It has a length of approximately 240 nucleotides and a 5'-end that is located at position -20 relative to the start codon. CPeB1-AS1 is expressed in all cell types and is highly conserved across different organisms, with only minor differences in its expression levels.

CPeB1-AS1 plays a critical role in regulating gene expression in the cell. It functions as an antisense RNA, meaning that it binds to a specific mRNA and prevents it from being translated into protein. This process is known as post-transcriptional repression, and it can effectively reduce the amount of a protein produced from a given mRNA. CPeB1-AS1 is highly effective at inhibiting the translation of certain target mRNAs, and it has been shown to play a key role in the regulation of various cellular processes, including cell growth, apoptosis, and transcriptional regulation.

CPEB1-AS1 is also known for its role in cancer progression. Studies have shown that CPeB1-AS1 levels are highly correlated with the development and progression of various cancers, including lung cancer, breast cancer, and colon cancer. Additionally, CPeB1-AS1 has has been shown to play a critical role in the regulation of cell cycle progression, which is a key factor in cancer progression.

Drug Target Potential

CPeB1-AS1's potential as a drug target is due to its unique mechanism of action and its involvement in various cellular processes. One of the key advantages of CPeB1-AS1 as a drug target is its high stability, which allows for the development of small interfering RNA (siRNA) based therapies. SiRNA is a type of RNA that can be used to knockdown gene expression in a specific cell or organism.

CPeB1-AS1 has been shown to play a critical role in the regulation of gene expression in various cell types, including cancer cells. By inhibiting its translation into protein, CPeB1-AS1 can effectively reduce the amount of a protein produced from a given mRNA. This can result in the downregulation of the target mRNA and the inhibition of its protein production.

Another potential mechanism by which CPeB1-AS1 could be used as a drug target is its role in cell signaling pathways. CPeB1-AS1 has been shown to play a critical role in the regulation of various signaling pathways, including the TGF-β pathway. This The pathway is involved in cell signaling and has been implicated in a variety of cellular processes, including cell growth, apoptosis, and transcriptional regulation.

Biomarker Potential

CPeB1-AS1 has also been identified as a potential biomarker for various diseases, including cancer. The levels of CPeB1-AS1 have been shown to be highly correlated with the development and progression of these diseases. This suggests that CPeB1-AS1 may be a useful biomarker for the diagnosis and monitoring of various diseases, including cancer.

One of the key advantages of CPeB1-AS1 as a biomarker is its stability and the ease with which it can be used for detection. CPeB1-AS1 is a small molecule and can be easily isolated and detected using various techniques, such as qRT-PCR and western blotting. This makes it an attractive option for the development of new diagnostic tests for various diseases.

Conclusion

CPeB1-AS1 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique mechanism of action and its involvement in various cellular processes make it an attractive option for the development of new therapeutic strategies for various diseases. Further research is needed to fully understand the role of CPeB1-AS1 in the regulation of gene expression and its potential as a drug target and biomarker.

Protein Name: CPEB1 Antisense RNA 1

The "CPEB1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CPEB1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets